|
|
Canertinib(CI-1033)
Description of:Canertinib(CI-1033)
CI-1033 effectively inhibits the growth of esophageal squamous cell carcinoma which co-expresses both EGFR a...
更多>>
|
|
|
|
Canertinib dihydrochloride
Description of:Canertinib dihydrochloride
An orally bioavailable tyrosine kinase inhibitor, targeting EGFR, irreversibly inhibiting their signa...
更多>>
|
|
|
|
Tandutinib
Description of:Tandutinib
Tandutinib (MLN518) is a FLT3 inhibitor. In cell-based assays Tandutinib inhibited FLT3 ,PDGFR, and KIT with IC50 val...
更多>>
|
|
|
|
KW2449
Description of:KW2449
KW-2449 potently and selectively inhibits the growth of leukemia cells harboring constitutively activated FLT3 kinase bot...
更多>>
|
|
|
|
AC220
Description of:AC220
AC220 exhibits low nanomolar potency in biochemical and cellular assays and exceptional kinase selectivity, and in animal ...
更多>>
|
|
|
|
Linifanib
Description of:Linifanib
The kinase inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 values of 2, 4 and...
更多>>
|
|
|
|
Danusertib(PHA-739358)
Description of:Danusertib(PHA-739358)
PHA-739358 is a pyrrolo-pyrazole, which inhibits Aurora kinases in a biochemical assay with IC50s of 13, ...
更多>>
|
|
|
|
AP24534(Ponatinib)泊那替尼
Description of:AP24534(Ponatinib)
AP24534 is a novel potent, orally available small molecule multitargeted kinase inhibitor with IC50 of 0.37, ...
更多>>
|
|
|
|
BGJ398
Description of:BGJ398
BGJ398 is a pan FGFR kinase inhibitor, and BGJ398 is an orally bioavailable pan inhibitor of human fibroblast g...
更多>>
|
|
|
|
BIBF-1120
Description of:BIBF-1120
BIBF-1120 (Vargatef) is an inhibitor of VEGFR, PDGFR and FGFR. all three VEGFR subtypes (IC50=13–34nmol/L) , PDG...
更多>>
|
|
Antibody-drug Conjugate/ADC Related
Trk Receptor
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian